Pharmacogenetics of antidepressant response: a polygenic approach
Judit García‐González, Katherine E. Tansey, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole N Mors, Anna Placentino, Marcella Rietschel, Daniel Souery, Tina Žagar, Piotr M. Czerski, Borut Jerman, Henriette N. Buttenschøn, Thomas G. Schulze, Astrid W. Zobel, , Chiara Fabbri
This study investigates whether polygenic risk scores (PRS) can predict antidepressant response in MDD, finding no significant predictive effect.
Progress in Neuro-Psychopharmacology and Biological Psychiatry · Jan 31, 2017Peer-reviewedGenetics